Search Results

Slidesets
SARS-CoV-2 Evolution: Where Do We Go From Here? - Jacob E. Lemieux, MD, DPhil
Presented at:
COVID-19 Clinical Forum 2022
Abstracts
Pediatric dolutegravir (DTG) dosing recommendations derived from combined P1093 and ODYSSEY Population Pharmacokinetic analysis
R. Singh Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Optimisation of First-Line Antiretroviral Therapy (ART) for Children Living with HIV in Uganda: Translation from policy to action
E. Namusoke Magongo  Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Optimisation of First-Line Antiretroviral Therapy (ART) for Children Living with HIV in Uganda: Translation from policy to action
E. Magongo Reviews in Antiviral Therapy & Infectious Diseases 7, 2020  
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Infection with subtype D adversely affects the live expectancy among people living with HIV – data from Northwestern Poland
M. Parczewski Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Females Who Inject Drugs in Nigeria - Lessons from Key Population Size Estimation Study of 10 States
A. Adesina Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Tracking Silent Transfers Using Electronic HIV Case Based Surveillance: Experience from Livingstone District in Zambia
S. Sivile Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020